Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Preferred Stock Liabilities (2018 - 2019)

TransMedics (TMDX) has 2 years of Preferred Stock Liabilities data on record, last reported at $186.5 million in Q1 2019.

  • For Q1 2019, Preferred Stock Liabilities changed N/A year-over-year to $186.5 million; the TTM value through Mar 2019 reached $186.5 million, changed N/A, while the annual FY2018 figure was $186.5 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $186.5 million in Q1 2019 per TMDX's latest filing, roughly flat from $186.5 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $186.5 million in Q4 2018 and bottomed at $186.5 million in Q4 2018.